Limits...
Can exercise capacity assessed by the 6 minute walk test predict the development of major adverse cardiac events in patients with STEMI after fibrinolysis?

Hassan AK, Dimitry SR, Agban GW - PLoS ONE (2014)

Bottom Line: The mean age was 60.9±10.7 years, 71.9% of them were males, 2/3 had anterior MI. only 10.5% had successful thrombolysis.There was a significant negative correlation between the 6 MWTD and GRACE risk score (r = -0.80, p<0.001).Multivariate logistic regression analysis identified that the GRACE risk score and 6MWT distance levels were the best predictors of the MACE at 3 month of follow up.

View Article: PubMed Central - PubMed

Affiliation: Department of Cardiovascular Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt.

ABSTRACT

Background: To assess the added value of the 6 minute walk test distance (6MWTD) in the risk-stratification methods for patients with ST -segment elevation myocardial infarction (STEMI) treated with fibrinolysis.

Methodology/principal findings: This is a prospective cohort study of one hundred consecutive patients with STEMI, who had received fibrinolysis, at Assuit University Hospital. All patients underwent 6MWT pre- discharge and were followed up for 3 months to monitor the incidence of major adverse cardiac events (MACE). Patients were divided into 3 groups according to the level of 6MWTD (level I>450 m, level II = 300-450 m and level III<300 m). Among the study population, the median 6MWT distance was 370 meters (interquartile range 162-462). The mean age was 60.9±10.7 years, 71.9% of them were males, 2/3 had anterior MI. only 10.5% had successful thrombolysis. Compared to patients in level I (>450 m), patients in level III (<300 m) were more likely to have clinical risk factors as hypertension, diabetes and impaired renal function. The patient's mean TIMI score was 3.4±2.2, the mean GRACE score was 150.5±27.7. There was a significant negative correlation between the 6 MWTD and GRACE risk score (r = -0.80, p<0.001). At 3 months of follow-up, 51% had MACE including 16% were dead. Multivariate logistic regression analysis identified that the GRACE risk score and 6MWT distance levels were the best predictors of the MACE at 3 month of follow up. The incidence of MACE was 4 times higher in patients with high GRACE risk score who couldn't walk more than 300 meters (OR = 4.66, 95% CI = 1.1-14.5, p = 0.006).

Conclusions/significance: In patients with STEMI treated with fibrinolysis, the addition of 6MWTD assessment pre-discharge to the traditional GRACE risk score improved the risk prediction of cardiovascular events at 3 month follow up.

Show MeSH

Related in: MedlinePlus

Cardiovascular events by levels of six-minute walk test distance.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4048282&req=5

pone-0099035-g002: Cardiovascular events by levels of six-minute walk test distance.

Mentions: All patients were followed up for 90 days. Cumulative MACE occurred in 51 patients. 12 patients had heart failure hospitalization, 10 patients had re-infarction, 13 patients had post MI angina and 16 patients died (table 3). Incidence of MACE was higher in patients with level III compared to other levels of 6MWT distance (Figure 2).


Can exercise capacity assessed by the 6 minute walk test predict the development of major adverse cardiac events in patients with STEMI after fibrinolysis?

Hassan AK, Dimitry SR, Agban GW - PLoS ONE (2014)

Cardiovascular events by levels of six-minute walk test distance.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4048282&req=5

pone-0099035-g002: Cardiovascular events by levels of six-minute walk test distance.
Mentions: All patients were followed up for 90 days. Cumulative MACE occurred in 51 patients. 12 patients had heart failure hospitalization, 10 patients had re-infarction, 13 patients had post MI angina and 16 patients died (table 3). Incidence of MACE was higher in patients with level III compared to other levels of 6MWT distance (Figure 2).

Bottom Line: The mean age was 60.9±10.7 years, 71.9% of them were males, 2/3 had anterior MI. only 10.5% had successful thrombolysis.There was a significant negative correlation between the 6 MWTD and GRACE risk score (r = -0.80, p<0.001).Multivariate logistic regression analysis identified that the GRACE risk score and 6MWT distance levels were the best predictors of the MACE at 3 month of follow up.

View Article: PubMed Central - PubMed

Affiliation: Department of Cardiovascular Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt.

ABSTRACT

Background: To assess the added value of the 6 minute walk test distance (6MWTD) in the risk-stratification methods for patients with ST -segment elevation myocardial infarction (STEMI) treated with fibrinolysis.

Methodology/principal findings: This is a prospective cohort study of one hundred consecutive patients with STEMI, who had received fibrinolysis, at Assuit University Hospital. All patients underwent 6MWT pre- discharge and were followed up for 3 months to monitor the incidence of major adverse cardiac events (MACE). Patients were divided into 3 groups according to the level of 6MWTD (level I>450 m, level II = 300-450 m and level III<300 m). Among the study population, the median 6MWT distance was 370 meters (interquartile range 162-462). The mean age was 60.9±10.7 years, 71.9% of them were males, 2/3 had anterior MI. only 10.5% had successful thrombolysis. Compared to patients in level I (>450 m), patients in level III (<300 m) were more likely to have clinical risk factors as hypertension, diabetes and impaired renal function. The patient's mean TIMI score was 3.4±2.2, the mean GRACE score was 150.5±27.7. There was a significant negative correlation between the 6 MWTD and GRACE risk score (r = -0.80, p<0.001). At 3 months of follow-up, 51% had MACE including 16% were dead. Multivariate logistic regression analysis identified that the GRACE risk score and 6MWT distance levels were the best predictors of the MACE at 3 month of follow up. The incidence of MACE was 4 times higher in patients with high GRACE risk score who couldn't walk more than 300 meters (OR = 4.66, 95% CI = 1.1-14.5, p = 0.006).

Conclusions/significance: In patients with STEMI treated with fibrinolysis, the addition of 6MWTD assessment pre-discharge to the traditional GRACE risk score improved the risk prediction of cardiovascular events at 3 month follow up.

Show MeSH
Related in: MedlinePlus